Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Trulieve Cannabis Corp (OP: TCNNF )

5.990 -0.130 (-2.12%)
Streaming Delayed Price Updated: 3:59 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Trulieve Cannabis Corp

< Previous 1 2 3 4 5 6 7 8 9
...
43 44 Next >
Finally, Tax Refunds! These Cannabis Companies Will Get The Most Money Back If Rescheduling Happens
Significant tax benefits are anticipated for the cannabis industry, following President Joe Biden's confirmation of the administration's intent to reschedule cannabis from Schedule I to Schedule III. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Biden's Greenlight: What To Know About Fed-Regulated Marijuana, Markets, Legal Circuits And Compliance
In an exclusive interview with Benzinga Cannabis, Aaron Bloom, an attorney and CEO of DocMJ, a multistate cannabis clinic, delved into the legal steps for rescheduling cannabis to Schedule III in the 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From May 16, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Weed Industry Celebrates Biden's Rescheduling Move: 'Most Monumental Cannabis Reform In Half A Century'
Cannabis companies and advocates applaud President Biden's announcement to reschedule and legalize cannabis, calling it a major leap forward and opportunity to correct long-standing wrongs and improve... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Wall Street Favorites: 3 Cannabis Stocks with Strong Buy Ratings for May 2024
Cannabis stocks to buy could see higher highs on several key catalysts. In fact, here are three stocks you may want to buy today. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
3 Cheap Cannabis Stocks to Buy Now: May 2024
With great growth potential and financials looking very positive, these three cannabis stocks are your best option for investment. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Florida Cannabis Legalization Amendment Ads Hit Airwaves: The First 4 Pitches For Legal Weed In The Sunshine State
The advocacy group's ads are being aired across the state over TV, radio, streaming and on digital sites. Having spent more than $5 million, the ads are criss-crossing the state to bring attention to... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Companies to Watch as Nasdaq Warms Up to Cannabis Listings
While it's uncertain if the Drug Enforcement Agency will reschedule marijuana, these are three cannabis stocks to watch if it does. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Analysts May Need To Revise Cannabis Stock Projections For 2024: 10 Companies Surpass EBITDA Estimates By $37M
Cannabis equity analysts may need to revise their 2024 earnings estimates after first-quarter results from major multi-state operators (MSOs). According to a recent report by Viridian Capital Advisors,... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Here's Where To Buy Legal Weed: Florida's Thriving Cannabis Landscape And More New Marijuana Stores In US And Canada
In anticipation of the outcome of Florida's Measure 3, cannabis giants are racing to bolster their retail footprint statewide. In California, four new cannabis stores kicked off sales recently. New... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Canadian Medical Marijuana Exports Rise Amid Falling Local Sales
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
The 7 Most Undervalued Cannabis Stocks to Buy in May 2024
Some of the most undervalued cannabis stocks could race to higher highs on several key catalysts this year. Here are seven. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
American Cannabis MSOs Portfolio Down 5% On The Week
Five of the 7 constituents released their Q1 financial reports earlier this week, contributing to a 5% decline in our portfolio for the week ending May 10. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Cannabis Reports Highlight $339M And $297.6M Revenue Insights In Curaleaf And Trulieve's Q1 2024 Financials
A recent Beacon Securities report focuses on Curaleaf's strategic financial management and the potential impacts of legislative changes on its operations. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Curaleaf Reports 16% Reduction In Net Loss In Q1 Financial Report
Curaleaf has evolved from an MSO to an MCO, a multi-country operator, doing business in 15 countries worldwide with the expectation of creating further separation from their peers. 
Via Talk Markets
Cannabis Stock Movers For May 9, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Trulieve Cannabis Q1 Financial Results Impressive: Revenue Loss Reduced 30%; Adj. EBITDA Up 20%
The Q1 financial results for Trulieve were released today and the results were impressive with a 30% reduction in its Net Income Loss and a 20% increase in its Adjusted EBITDA. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
TCNNF Stock Earnings: Trulieve Cannabis Beats EPS, Beats Revenue for Q1 2024
TCNNF stock results show that Trulieve Cannabis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Medical Marijuana Giant Trulieve, Backer Of Florida's Recreational Cannabis Ballot, Narrows Loss, Reports Uptick In Q1 Revenue, Gross Profit
Trulieve Cannabis Corp. announced on Thursday its first quarter results for the three months ended March 31, 2024. The Tallahassee, Florida-based medical cannabis giant reported revenue of $298 million... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?
These top cannabis stocks by revenue are among the world's best sellers, making them prime investment opportunities to capture legal changes. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Big Players In U.S. Cannabis Could Play The Stock-Value Card In M&A, New Report Shows
As the cannabis industry adapts to its new regulatory environment following the DEA's announcement it would move to  
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Retreat On New Rescheduling Order Developments: What's Going On?
The DEA was expected to move forward with its plans this week to remove cannabis as a Schedule 1 drug, where it currently sits alongside heroin and LSD, but new reports suggest the proposal has... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
420 with CNW — German Marijuana Imports Reached Record Levels in 2023
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Dropped 19%, On Average, In Last 3 Days Of This Week
The cannabis sector dropped 18.8% in the last 3 days and it probably has further to go, based on historical data.so the question now is how much further it will drop before stabilizing. Time will tell.... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
EXCLUSIVE: 'Cannabis Is Just Getting Started,' Says This Top Stock Expert Who Knows How To Capitalize On Swing Trades
"Cannabis is just getting started and there's going to be a lot of companies getting ready to take advantage of this massive growth cycle, government reform, news states, opening new opportunities and... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Credit Check: What Does DEA Rescheduling Mean For Cannabis Credit Ratings? Big Companies' Risk-Return Profiles
The recent decision by the DEA to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations of multi-state operators (MSOs). 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For May 1, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Billions On The Move: Tracking Market Cap Changes In Top Cannabis Firms After DEA Rescheduling Announcement
Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injected billions into the publicly traded market for cannabis companies. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Tuesday For Marijuana Stocks - Elixinol Wellness, Item 9 Labs Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana
The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decision to align its stance with a recommendation from the Department of Health and... 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
43 44 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.